18KIT
Getting a DOSE
A new partnership adds options for using insulin
pens for insulin delivery while linking seamlessly and
directly to clinic.
Together, we can
offer unparalleled
support to
patients and
healthcare
providers,
improving the
management
of injectable
therapies
worldwide ~
Dean Minnock
Glooko, Inc., a global
integrated digital health
company connecting
patients, providers,
biopharma, and medical device
partners, and Innovation Zed, a
pioneering developer of connected
add-on devices for drug delivery
devices, today announced a strategic
partnership to develop and deploy
digital companion apps with the
adaptive DOSE platform hardware
add-on technology for injectable
therapies. This collaboration aims
to revolutionize the management of
injectable medications by providing
comprehensive connectivity and data
capture solutions for dosing, storage,
and injection techniques.
Injectable therapies are
essential for managing many
chronic conditions, yet they pose
significant challenges. Complex
dosing regimens, fear of injections,
and variability in injection
technique can hinder adherence
to recommended and compromise
safety. Additionally, improper storage
can impact medication efficacy,
while limited data capture makes it
difficult to monitor patient progress
effectively. This collaboration aims
to address these challenges by
providing a comprehensive digital
solution that supports patients and
healthcare providers in optimizing
injectable therapies.
Innovative tech
This innovative digital companion
system, seamlessly integrating
hardware and software, will be
designed to integrate with the
Glooko platform, currently used by
more than 8,200 diabetes clinics
worldwide. This integration will
enable the capture and analysis
of critical information related
to injectable therapies from
Innovation Zed's DOSE platform
technology, offering enhanced
support for healthcare providers and
patients alike.
Benefits of digital companion apps:
• Improved adherence: Accurate
recording and monitoring of dosing
schedules to support adherence
and optimize therapy outcomes.
• Enhanced safety: Guidance on
proper storage conditions to
maintain medication efficacy and
educational resources on correct
injection techniques.
• Increased patient confidence:
Support and feedback on injection
techniques to improve patient
confidence and safety.
• Streamlined data management:
Real-time data capture and
connectivity for a wide range of
injectable medications, providing
valuable insights for healthcare
professionals.
Mike Alvarez, Chief Executive Officer
of Glooko comments, "We are
excited to partner with Innovation
Zed to bring this cutting-edge
digital companion system to market.
This collaboration will enable us
to provide comprehensive support
for patients and their healthcare
providers, ultimately enhancing